Formulation factors affecting absorption MCQs With Answer

Introduction: Formulation factors affecting absorption MCQs With Answer is designed for M.Pharm students preparing for Advanced Biopharmaceutics & Pharmacokinetics (MPH 202T). This collection focuses on how formulation variables — such as particle size, polymorphism, salt form, excipients, dosage form design, and solubilization strategies — influence the rate and extent of drug absorption. Questions explore mechanistic links between physicochemical properties and in vivo performance, covering dissolution, permeability, ionization, and excipient interactions. Each item challenges the student to apply principles to predict and optimize bioavailability. Use these MCQs to deepen understanding, identify knowledge gaps, and prepare for exams or formulation development decisions.

Q1. Which formulation modification most directly increases the dissolution rate of a poorly water-soluble crystalline drug by increasing surface area?

• Salt formation with a hydrophobic counterion
• Micronization to reduce particle size
• Addition of a permeation enhancer
• Enteric coating to delay release

Correct Answer: Micronization to reduce particle size

Q2. How does conversion from a crystalline to an amorphous form generally affect solubility and absorption potential?

• Decreases solubility and reduces absorption due to lower lattice energy
• Increases solubility and potentially enhances absorption due to higher free energy state
• No change in solubility but increases permeability
• Always improves chemical stability and shelf life

Correct Answer: Increases solubility and potentially enhances absorption due to higher free energy state

Q3. Which excipient class is most commonly used to improve wetting and thus increase dissolution of hydrophobic drug particles?

• Binders (e.g., povidone)
• Surfactants (e.g., sodium lauryl sulfate)
• Lubricants (e.g., magnesium stearate)
• Disintegrants (e.g., croscarmellose)

Correct Answer: Surfactants (e.g., sodium lauryl sulfate)

Q4. Why can conversion to a salt form improve oral absorption of a weakly acidic drug?

• Salt formation decreases the ionization in the intestine, reducing permeability
• Salt form increases aqueous solubility and dissolution rate at intestinal pH
• Salt forms always convert drugs to amorphous state
• Salt formation increases lipophilicity, decreasing solubility

Correct Answer: Salt form increases aqueous solubility and dissolution rate at intestinal pH

Q5. Which formulation strategy would most effectively maintain supersaturation in the GI lumen to enhance absorption of a BCS Class II drug?

• Use of hydrophobic coatings to slow release
• Inclusion of polymeric precipitation inhibitors (e.g., HPMC, PVP)
• Increasing tablet compression force to reduce porosity
• Adding high levels of insoluble fillers

Correct Answer: Inclusion of polymeric precipitation inhibitors (e.g., HPMC, PVP)

Q6. How does increasing formulation viscosity (e.g., in a suspension or gel) typically affect drug absorption from the GI tract?

• Increases absorption by enhancing diffusion rates
• Decreases absorption by slowing drug diffusion to the absorptive surface
• Has no effect on dissolution or permeability
• Always increases chemical stability and therefore absorption

Correct Answer: Decreases absorption by slowing drug diffusion to the absorptive surface

Q7. Which of the following best explains how lipid-based formulations (SMEDDS, self-emulsifying systems) enhance oral absorption of lipophilic drugs?

• They crystallize the drug to reduce dissolution
• They form micelles or emulsions that increase drug solubilization and lymphatic transport
• They increase gastric motility which increases residence time
• They prevent drug ionization in the GI tract

Correct Answer: They form micelles or emulsions that increase drug solubilization and lymphatic transport

Q8. Polymorphic form A of a drug has higher lattice energy than form B. Which statement is correct regarding absorption-related properties?

• Form A will be more soluble and absorb faster than form B
• Form A will be less soluble and likely have slower dissolution than form B
• Polymorphic differences do not affect dissolution or absorption
• Form A will always be more chemically stable and therefore more bioavailable

Correct Answer: Form A will be less soluble and likely have slower dissolution than form B

Q9. Which process during tablet manufacture can reduce drug absorption by forming a hydrophobic film around particles?

• Use of disintegrants
• Excessive use of hydrophobic lubricant like magnesium stearate and over-blending
• Proper granulation with hydrophilic binders
• Spray drying into porous particles

Correct Answer: Excessive use of hydrophobic lubricant like magnesium stearate and over-blending

Q10. What is the primary reason enteric coatings can alter the site and rate of absorption?

• They increase drug solubility in the stomach
• They prevent drug release in the stomach and enable release in the higher pH of the intestine
• They enhance systemic bioavailability by increasing permeability
• They convert drugs to their salt forms in situ

Correct Answer: They prevent drug release in the stomach and enable release in the higher pH of the intestine

Q11. Which formulation change would most likely increase the permeability-limited absorption of a highly polar drug?

• Micronization to reduce particle size
• Inclusion of permeation enhancers or prodrug approach
• Converting to an amorphous form
• Adding surfactants for wetting

Correct Answer: Inclusion of permeation enhancers or prodrug approach

Q12. Why can incorporation of cyclodextrins into a formulation improve oral absorption of some poorly soluble drugs?

• Cyclodextrins chemically react with the drug to form salts
• They form inclusion complexes that increase aqueous solubility and maintain dissolved drug
• They increase particle size and reduce dissolution
• They act as disintegrants to speed tablet breakup

Correct Answer: They form inclusion complexes that increase aqueous solubility and maintain dissolved drug

Q13. Which factor related to drug ionization most strongly affects oral absorption across different segments of the GI tract?

• Melting point of the drug
• Drug pKa relative to local pH (pH-partition hypothesis)
• Molecular weight alone
• Tablet color and flavoring

Correct Answer: Drug pKa relative to local pH (pH-partition hypothesis)

Q14. How does co-administration with a high-fat meal commonly influence absorption of lipophilic, highly permeable drugs formulated in a simple tablet?

• Decreases absorption by sequestering drug in the stomach
• Increases absorption via enhanced solubilization in bile salts and stimulation of lymphatic transport
• Has no impact on absorption for lipophilic drugs
• Always converts drugs to a crystalline less soluble form

Correct Answer: Increases absorption via enhanced solubilization in bile salts and stimulation of lymphatic transport

Q15. Which statement explains how controlled-release matrix tablets can lower peak plasma concentration (Cmax) without reducing total bioavailability for a drug with dissolution-limited absorption?

• The matrix increases dissolution rate to produce a higher Cmax
• The matrix sustains release, matching dissolution to absorption capacity and reducing peak but maintaining AUC
• The matrix converts drug to an insoluble form lowering AUC
• Controlled release always increases first-pass metabolism

Correct Answer: The matrix sustains release, matching dissolution to absorption capacity and reducing peak but maintaining AUC

Q16. Which formulation approach is most appropriate to bypass first-pass hepatic metabolism and potentially improve bioavailability for certain lipophilic drugs?

• Formulate as an immediate-release oral tablet
• Design for buccal or sublingual delivery
• Increase tablet hardness to delay disintegration
• Add hydrophobic fillers to the formulation

Correct Answer: Design for buccal or sublingual delivery

Q17. What is the likely effect of increasing drug crystallinity in a solid dispersion intended to enhance oral absorption?

• Improves dissolution and absorption by stabilizing the amorphous fraction
• Reduces apparent solubility and may decrease absorption relative to amorphous dispersion
• Has no impact because crystallinity is irrelevant in solid dispersions
• Always increases permeability across membranes

Correct Answer: Reduces apparent solubility and may decrease absorption relative to amorphous dispersion

Q18. Which formulation factor can paradoxically reduce absorption by creating a supersaturated solution that quickly precipitates in the GI tract?

• Use of precipitation inhibitors
• Rapid-release lipid formulation without stabilization, causing high local supersaturation
• Inclusion of hydrophilic polymers
• Conversion to a stable salt form

Correct Answer: Rapid-release lipid formulation without stabilization, causing high local supersaturation

Q19. In oral peptide formulations, which excipient strategy is often employed to improve epithelial transport and protect from enzymatic degradation?

• Use of enteric coatings only
• Protease inhibitors combined with permeation enhancers
• Increasing particle size to limit contact with enzymes
• Adding insoluble fillers to prevent dissolution

Correct Answer: Protease inhibitors combined with permeation enhancers

Q20. Which manufacturing parameter of solid oral dosage forms is most directly linked to the rate of disintegration and subsequent drug absorption?

• Storage temperature only
• Compression force used during tableting
• Color of the tablet coating
• Manufacturer’s logo embossing

Correct Answer: Compression force used during tableting

Download